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Abstract
Background: A retrospective comparative study was designed to determine whether the
transvalvular gradient has a predictive value in the assessment of operative outcome in patients
with severe aortic stenosis and poor left ventricular function.
Methods: From a surgical database, a series of 30 consecutive patients, who underwent isolated
aortic valve replacement for severe aortic stenosis with depressed left ventricular (LV) function (EF
< 40%), were enrolled in the study and divided into two groups according to the mean transvalvular
gradient (TVG): LG(low gradient)-Group < 40 mmHg (n = 13), and HG(high gradient)-Group > 40
mmHg (n = 17). Both groups were then comparatively assessed with respect to perioperative
organ functions and mortality.
Results: Both groups were well matched with respect to the preoperative clinical status. LG-
Group had a larger aortic valve area, higher LVEDP, larger LVESD and LVEDD, and higher mean
pulmonary pressures. The immediate postoperative outcome, hospital morbidity and mortality did
not differ significantly among the groups.
Conclusion: In patients with severe aortic stenosis and poor LV function, the mean transvalvular
gradient, although corresponds to reduced LV performance, has a limited prognostic value in the
assessment of surgical outcome. Generally, operating on this select group of patients is safe.
Background
In patients with severe aortic stenosis (AS) scheduled for
aortic valve replacement (AVR), the operative risk as well
as the late postoperative outcome increases with the onset
of LV systolic and diastolic dysfunction [1,2]. As the
results of AVR in patients with severely reduced LV func-
tion and low TVG are uncertain, this patient subset still
remains the most controversial in terms of decision mak-
ing for surgery [3].
Few data are available on the immediate postoperative
and long-term outcome in patients with isolated severe AS
and poor LV function, especially in regard to the severity
of TVG.
We tested the hypothesis that AVR in patients with iso-
lated severe AS and poor LV function, the mean TVG has
no impact on immediate postoperative outcome. Indica-
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in the literature are discussed.
Methods
From our surgical database including a total number of
1117 patients who between 1992 and 2002 underwent
AVR, a series of 30 consecutive patients with severe aortic
stenosis associated with depressed LV function, was
selected for the study.
Inclusion criteria were: LVEF < 40 %, and aortic valve area
(AVA) of < 1 cm2 (additionally confirmed at surgery).
Patients with associated coronary heart disease (CHD) or
concomitant valve procedure or with significant aortic
valve regurgitation were excluded from the study. All
study patients were operated on under conditions of
extracorporeal circulation (ECC), using moderate hypo-
thermia, and Bretschneider's cardioplegic solution for
myocardial protection.
The study cohort was divided into two groups according
to the level of the mean TVG: LG-Group < 40 mmHg, and
HG-Group > 40 mmHg. Due to a relatively high percent-
age of patients with atrial fibrillation, mean gradients
were used to define study groups [4]. The pre-, peri- and
postoperative data of both groups were comparatively
analysed.
The preoperative data collection included: demographic
data, clinical symptoms with special regard to respiratory
insufficiency and NYHA functional class, rhythm distur-
bances, admission-to-surgery interval, degree of urgency,
echocardiographic examination, cardiac catheterization,
organ functions, and need for preoperative emergency
balloon valvuloplasty. Respiratory insufficiency was
defined as the need for non-invasive (face mask) or inva-
sive mechanical ventilation.
As relevant perioperative data, type and size of the pros-
thetic valve implanted, the effective orifice area index (cal-
culated as EOA divided by body surface area, EOA/
BSA=EOA-I), ischemia- and ECC-time, catecholamine
and/or mechanical circulatory support were considered.
The postoperative data comprised assessment of organ
functions, catecholamine and mechanical circulatory sup-
port, mechanical ventilation time, duration of stay at
intensive care unit, and hospital mortality and morbidity.
The inotropic support was defined as high, when epine-
phrine with a dosage of > 6 µg/kg b.w./min, moderate
with 4–6 µg/kg b.w./min, and low with < 4 µg/kg b.w./
min, for at least 48 h, was administered.
Results
The demographic and preoperative clinical data of both
patient groups are presented in Table 1. With regard to
preoperative organ finctions, 3 patients in LG-Group and
5 patients in HG-Group had increased creatinine level
(1.6–2.8 mg/dl vs 1.7–2.4 mg/dl). In 2 patients in LG-
Group and 6 patients in HG-Group, increased liver
transaminase level with GOT values between 35–280 U/l
and GPT values between 90–325 U/l, respectively, were
observed.
The admission-to-surgery time interval was considerably
longer in LG-patient group, whereas in 2 patients in LG-
Group und 3 patients in HG-Group, due to a rapid deteri-
oration of circulatory conditions, surgery was performed
Table 1: Preoperative data
LG-Group n = 13 HG-Group n = 17
f/m ratio (n) 2:11 8:9
Age (y, mean, range) 65 (43–77) 69 (33–86)
Symptoms:
Dyspnoea 11 pts (85%) 12 pts (70%)
Respiratory insufficiency 5 pts (38%) 6 pts (35%)
Syncope 2 pts (15%) 1 pt (6%)
Cardiogenic shock 2 pts (15%) 2 pts (11%)
AF 4 pts (30%) 4 pts (23%)
Balloon valvuloplasty 0 pt 2 pts (11%)
NYHA class III/IV 9 pts (69%) 12 pts (70%)
Priority:
Emergent 2 pts (15%) 3 pts (17%)
Admission-to-surgery
interval (d, mean, range) 33.2 (5–85) 11.5 (1–60)
EuroSCORE (mean, range)
logistic (%) 22.3 (2.77–59.48) 21.03 (3.13–84.53)
additive 9.8 (3–16) 9.4 (5–19)
AF atrial fibrillation, d days, f/m female/male, h hours, HG high gradient, LG low gradientPage 2 of 5
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insufficiency in LG-Group and one of 6 patients in HG-
Group required mechanical ventilation. The preoperative
hemodynamic situation with echocardiographic and car-
diac catheterization data for both patient groups are sum-
marized in Table 2.
The median size of implanted valves was 25 mm and 23
mm for LG- and HG-Group, respectively. In LG-Group, 10
mechanical valves (9 SJM HP Type, 1 SJM Regent, St. Jude
Inc., St.Paul, MN, USA) and 3 biological valves (Baxter
Perimount, Baxter Healthcare Corporation, Irvine, CA,
USA) were implanted. In HG-Group, 11 patients received
mechanical (SJM HP), and 6 patients biological (Baxter
Perimount) valve prosthesis.
The EOA-I was calculated 1.48 ± 0.28, median 1.41, range
0.94–1.93 for LG-Group, and 1.39 ± 0.27, median 1.43,
range 0.88–1.8 for HG-Group.
The mean myocardial ischemia time (aortic cross-clamp)
for LG- and HG-Group were with 65 and 67 minutes, and
the mean ECC duration 102 and 123 minutes, respec-
tively. The immediate postoperative catecholamine sup-
port was comparable among the groups: in LG-Group, 4
patients needed high, 5 patients moderate, and in HG-
Group, 5 patients high, and 5 patients moderate inotropic
support; 2 patients in LG-Group and 3 patients in HG-
Group were implanted with intraaortic ballon pump for
mechanical circulatory support.
The relevant postoperative data are summarized in Table
3.
Discussion
Patients with severe LV dysfunction, particularly those
with low TVG, although account for only 5–10% of
patients with AS, represent most controversial subset with
a difficult management decision [3]. The underlying man-
agement problems focus on the operative mortality and
potential for recovery of LV function.
In recent studies, perioperative mortality in patients with
AS and LV dysfunction is reported to vary between 3% and
62%, and the results are strongly dependent on underly-
ing hemodynamic conditions and/or concomitant proce-
dures [5-7]; e.g. patients with severe AS and associated
CHD are considered as a subset with increased periopera-
tive risk [8,9].
The contractile reserve (CR) seems to play an essential role
for operative outcome.
Low perioperative mortality rates of 5% and 3% were pub-
lished by Monin [5,10] and Powell [8], respectively, in
patients with isolated AS and LV dysfunction and with
dobutamine proven CR. Schwammenthal [7], based on
Dobutamine Stress Echocardiography (DSE), in patients
with AS and severe LV dysfunction, observed good surgi-
cal outcome when the clinical decision was concordant
with the results of DSE.
In attempt to define the criteria for selecting the patients
who will benefit from AVR, Monin [5], based on the
results of a multicentre study, assessed the prognostic
value of dobutamine stress hemodynamic data in the set-
ting of low-gradient AS: predictors for operative mortality
were the lack of CR and a mean TVG < 20 mmHg (mortal-
ity 5% vs 32%). The author finally concluded that predic-
tive value of the lack of CR in terms of postoperative
changes is still not known. Quere [11] observed that
absence of CR is related to high operative mortality but
does not predict the absence of LVEF recovery, suggesting
that surgery should not be contraindicated on the basis of
absence of CR alone.
A summarized review of surgical outcome in recent series
is depicted in Table 4.
Table 2: Preoperative echocardiographic and cardiac catheterization data
Parameters LG-Group HG-Group
TVG (mmHg) 35 (25–40) 90 (60–120)
LVEF (%) 30 (12–40) 25 (15–40)
AVA (cm2) 0.7 (0.6–0.9) 0.5 (0.3–0.6)
LVEDP (mmHg) 40 (20–44) 24 (18–32)
LVESD (mm) 50 (39–64) 44 (24–50)
LVEDD (mm) 70 (52–74) 60 (46–70)
PAP (mmHg) 44 (25–80) 30 (18–90)
C.I. (L/min/m2) 1.8 (1.7–2.2) 2.0 (1.8–2.5)
AVA aortic valve area, C.I. Cardiac index, HG high gradient, LG low gradient, LVEDD left ventricular end-diastolic diameter, LVEDP left ventricular 
end-diastolic pressure, LVEF left ventricular ejection fraction, LVESD left ventricular end-systolic diameter, PAP pulmonary artery pressure, TVG 
mean aortic transvalvular gradient
Data are given as mean values with ranges in bracketsPage 3 of 5
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increased risk for perioperative mortality, generally, LV
performance recovers after AVR [12,13]. Brogan [14]
reported, that some of the patients with severe AS and
severe LV dysfunction, and preoperative NYHA functional
class III/IV were found to be in class I after 8–36 months
postoperatively. Nishimura [15] suggested that, despite
comparable poor preoperative cardiac performance, a
very different recovery potential of the failing heart is pos-
sible. Rothenburger [16] reported at a follow-up of 1 year
after AVR, an improvement of EF of up to 40%. In recent
studies [8,10,15], a postoperative increase of EF at an ava-
rage of up to 100% during a follow-up time of 3–5 years
was also observed. It should be stressed however, that in
the most recent relevant studies, all patient groups with
severe AS and severe LV dysfunction who underwent AVR
were relatively small, and had concomitant CABG proce-
dure or no informations about the concomitant proce-
dures were given [5,7,10,15].
Limitations of the study
In none of our patients a DSE was performed.
For comparison, two patient cohorts with low- and high
TVG, both with severely depressed LV function were
selected. Reduced EF is considered to be related to exces-
sively high wall stress due to insufficient hypertrophy and
not irreversibly impaired contractility [2,17]. If so, the
ability to develop/increase the TVG despite severe LV dys-
function can be interpret as a available CR. And congru-
ently, with comparable mean LVEF for both groups in our
patient collective, the HG-patient group had considerably
smaller LVEDD and LVESD, lower LVEDP- and PAP-val-
ues. One can therefore assume that patients in LG group
had a lower CR when compared to HG-Group. Although
not statistically proven, our observations are contradic-
tory to those published by Monin [18], who stated that in
the setting of poor LV-function, the decrease of TVG has
an independent prognostic value for operative risk.
Conclusion
Despite higher degree of LV dysfunction, our patients with
low gradients had comparable outcome to those with
high gradients, suggesting that operating on this select
group of patients is a safe procedure. However, in high
risk patients, preoperative risk assessment with estimation
of myocardial contraction reserve, adequate judgment of
severity of aortic stenosis, consideration of co-morbidity
and need for concomitant procedures are mandatory to
Table 3: Postoperative data
LG-Group HG-Group
Mechanical ventilation (h, mean, range) 13 (6–48) 22 (6–72)
CVVH 2 pts (15%) 4 pts (23%)
Rethoracotomy for bleeding 3 pts (23%) 2 pts (11%)
Permanent a-v block III° 1 pt (7%) 1 pt (6%)
IABP 2 pts (15%) 3 pts (17%)
ICU stay (d, mean, range) 3.7 (1–12) 5.4 (2–19)
Mortality 1 pt (7%) 1 pt (6%)
CVVH continuous veno-venous hemofiltration, d days, h hours, HG high gradient, IABP intraaortic balloon pump, ICU intensive care unit, LG low 
gradient
Table 4: Outcome in recent series
Author n EOA/EF PtsCHD Mortality
Total -CHD +CR -CR +CR +CHD -CR +CHD
Connolly [3] 52 < 0.9/< 35 62% 21%
Monin [5]* 136 < 0.8/< 35 40% 14% 5% 32% 11% 62%
Powell [8] 55 < 0.75/< 30 36% 18% 3%
Tarantini [9] 52 < 1.0/< 35 30% 8%
Monin [10] 30 < 0.8/< 30 43% 16% 8% 50%
Nishimura [15] 21 < 1.0/< 40 70% 14% 14%
EOA/EF effective orifice area (cm2)/ejection fraction (%), PtsCHD proportion of patients with coronary heart disease, Mortality:-CHD patients without 
coronary heart disease, +CHD patients with coronary heart disease, -CR patients with no contraction reserve, +CR patients with contraction 
reserve, periop perioperative, n number of patients, * multicentre studyPage 4 of 5
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avoid operating on patients who will not benefit from sur-
gery [5,7-9,14,19].
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